Intrinsic value of Krystal Biotech, Inc. (KRYS)

Live fair value data for Krystal Biotech, Inc. (KRYS) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +37.0%

Margin of Safety: +27.0%

Current Price: $129.00

Valuation: Undervalued

Confidence: 8.0/10

Visual Bar

Market Price $129.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Krystal Biotech, Inc. (KRYS) undervalued or overvalued?

Based on the current model output, Krystal Biotech, Inc. appears to be undervalued with a upside of 37.00%.

Fair value vs market price — Krystal Biotech, Inc. (KRYS)

Unlock premium access to view the live fair value comparison against current market price for KRYS.

Frequently Asked Questions - KRYS

How is KRYS intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for KRYS.

Is KRYS undervalued or overvalued right now?

KRYS is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for KRYS: open their intrinsic value pages.

Explore Other Stocks